USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop

Yes-associated protein (YAP) is an essential driver of hepatocellular carcinoma (HCC) progression and the ubiquitin-proteasome system controls its abundance. However, the role of ubiquitin-specific protease 40 (USP40) in YAP stability remains unclear. Here, USP40 was first identified as a novel regu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2024-05, Vol.589, p.216832-216832, Article 216832
Hauptverfasser: Mo, Huanye, Li, Runtian, Yang, Nan, Han, Jiaqi, Xiao, Xuelian, Zhang, Yilei, Xiao, Zhengtao, Jiao, Lianying, Xu, Qiuran, Tu, Kangsheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 216832
container_issue
container_start_page 216832
container_title Cancer letters
container_volume 589
creator Mo, Huanye
Li, Runtian
Yang, Nan
Han, Jiaqi
Xiao, Xuelian
Zhang, Yilei
Xiao, Zhengtao
Jiao, Lianying
Xu, Qiuran
Tu, Kangsheng
description Yes-associated protein (YAP) is an essential driver of hepatocellular carcinoma (HCC) progression and the ubiquitin-proteasome system controls its abundance. However, the role of ubiquitin-specific protease 40 (USP40) in YAP stability remains unclear. Here, USP40 was first identified as a novel regulator of YAP abundance and its target genes in HCC cells. USP40 interacted with YAP to remove the lysine 48 (K48)-linked polyubiquitination of YAP at K252 and K315 sites, thereby maintaining YAP stability. USP40 facilitated the proliferation, colony formation, migration and spheroid formation of HCC cells in vitro and promoted HCC growth in vivo in a YAP-dependent manner. In turn, YAP transcriptionally activated USP40 expression in HCC cells. RNA sequencing analysis showed that about 37% of USP40-regulated genes overlapped with YAP-regulated genes. Interestingly, stiffness-induced USP40 upregulation was abolished by YAP knockdown, and USP40 knockdown attenuated stiffness-induced YAP accumulation in HCC cells. Clinical data demonstrated that USP40 was positively associated with YAP expression in HCC tissues and its high expression indicated a poor prognosis. In conclusion, the USP40/YAP positive feedback loop contributes to HCC progression, suggesting that USP40 may be a promising drug target for anti-HCC. •USP40 stabilizes YAP by removing the polyubiquitination chain of YAP.•USP40 facilitates HCC cell proliferation and migration by enhancing YAP expression.•YAP transcriptionally activated USP40 expression in HCC cells.•USP40 and YAP overexpression were frequently detected and correlated with poor prognosis in HCC.
doi_str_mv 10.1016/j.canlet.2024.216832
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3014012341</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383524002258</els_id><sourcerecordid>3014012341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-dae25b5dd9a501bda5356179f514b52b463bb25a9de99d587f61f1f7c73ba6093</originalsourceid><addsrcrecordid>eNp9kMtKxEAQRRtRdHz8gUiWbjL2M51sBBFfICioCzc2_ag4PSbpsTsR_HszZHTpqjbnVtU9CB0TPCeYFGfLudVdA_2cYsrnlBQlo1toRkpJc1mVeBvNMMM8ZyUTe2g_pSXGWHApdtEeKwWTUvIZent5euQ4W8XQhh5StoCV7oOFphkaHTOro_VdaPWaeI-Qkg9d1i9iGN4Xmc5eLx7PNhtC8r3_gqwGcEbbj6wJYXWIdmrdJDjazAP0cn31fHmb3z_c3F1e3OeWEdLnTgMVRjhXaYGJcVowURBZ1YJwI6jhBTOGCl05qConSlkXpCa1tJIZXeCKHaDTae_45ucAqVetT-sWuoMwJMUw4ZhQxsmI8gm1MaQUoVar6FsdvxXBam1WLdVkVq3NqsnsGDvZXBhMC-4v9KtyBM4nAMaeXx6iStZDZ8H5CLZXLvj_L_wAWAqLoA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3014012341</pqid></control><display><type>article</type><title>USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop</title><source>Elsevier ScienceDirect Journals Collection</source><creator>Mo, Huanye ; Li, Runtian ; Yang, Nan ; Han, Jiaqi ; Xiao, Xuelian ; Zhang, Yilei ; Xiao, Zhengtao ; Jiao, Lianying ; Xu, Qiuran ; Tu, Kangsheng</creator><creatorcontrib>Mo, Huanye ; Li, Runtian ; Yang, Nan ; Han, Jiaqi ; Xiao, Xuelian ; Zhang, Yilei ; Xiao, Zhengtao ; Jiao, Lianying ; Xu, Qiuran ; Tu, Kangsheng</creatorcontrib><description>Yes-associated protein (YAP) is an essential driver of hepatocellular carcinoma (HCC) progression and the ubiquitin-proteasome system controls its abundance. However, the role of ubiquitin-specific protease 40 (USP40) in YAP stability remains unclear. Here, USP40 was first identified as a novel regulator of YAP abundance and its target genes in HCC cells. USP40 interacted with YAP to remove the lysine 48 (K48)-linked polyubiquitination of YAP at K252 and K315 sites, thereby maintaining YAP stability. USP40 facilitated the proliferation, colony formation, migration and spheroid formation of HCC cells in vitro and promoted HCC growth in vivo in a YAP-dependent manner. In turn, YAP transcriptionally activated USP40 expression in HCC cells. RNA sequencing analysis showed that about 37% of USP40-regulated genes overlapped with YAP-regulated genes. Interestingly, stiffness-induced USP40 upregulation was abolished by YAP knockdown, and USP40 knockdown attenuated stiffness-induced YAP accumulation in HCC cells. Clinical data demonstrated that USP40 was positively associated with YAP expression in HCC tissues and its high expression indicated a poor prognosis. In conclusion, the USP40/YAP positive feedback loop contributes to HCC progression, suggesting that USP40 may be a promising drug target for anti-HCC. •USP40 stabilizes YAP by removing the polyubiquitination chain of YAP.•USP40 facilitates HCC cell proliferation and migration by enhancing YAP expression.•YAP transcriptionally activated USP40 expression in HCC cells.•USP40 and YAP overexpression were frequently detected and correlated with poor prognosis in HCC.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2024.216832</identifier><identifier>PMID: 38537774</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Hepatocellular carcinoma ; Stiffness ; Tumor progression ; USP40 ; YAP</subject><ispartof>Cancer letters, 2024-05, Vol.589, p.216832-216832, Article 216832</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-dae25b5dd9a501bda5356179f514b52b463bb25a9de99d587f61f1f7c73ba6093</cites><orcidid>0000-0002-0032-1459</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304383524002258$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38537774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mo, Huanye</creatorcontrib><creatorcontrib>Li, Runtian</creatorcontrib><creatorcontrib>Yang, Nan</creatorcontrib><creatorcontrib>Han, Jiaqi</creatorcontrib><creatorcontrib>Xiao, Xuelian</creatorcontrib><creatorcontrib>Zhang, Yilei</creatorcontrib><creatorcontrib>Xiao, Zhengtao</creatorcontrib><creatorcontrib>Jiao, Lianying</creatorcontrib><creatorcontrib>Xu, Qiuran</creatorcontrib><creatorcontrib>Tu, Kangsheng</creatorcontrib><title>USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Yes-associated protein (YAP) is an essential driver of hepatocellular carcinoma (HCC) progression and the ubiquitin-proteasome system controls its abundance. However, the role of ubiquitin-specific protease 40 (USP40) in YAP stability remains unclear. Here, USP40 was first identified as a novel regulator of YAP abundance and its target genes in HCC cells. USP40 interacted with YAP to remove the lysine 48 (K48)-linked polyubiquitination of YAP at K252 and K315 sites, thereby maintaining YAP stability. USP40 facilitated the proliferation, colony formation, migration and spheroid formation of HCC cells in vitro and promoted HCC growth in vivo in a YAP-dependent manner. In turn, YAP transcriptionally activated USP40 expression in HCC cells. RNA sequencing analysis showed that about 37% of USP40-regulated genes overlapped with YAP-regulated genes. Interestingly, stiffness-induced USP40 upregulation was abolished by YAP knockdown, and USP40 knockdown attenuated stiffness-induced YAP accumulation in HCC cells. Clinical data demonstrated that USP40 was positively associated with YAP expression in HCC tissues and its high expression indicated a poor prognosis. In conclusion, the USP40/YAP positive feedback loop contributes to HCC progression, suggesting that USP40 may be a promising drug target for anti-HCC. •USP40 stabilizes YAP by removing the polyubiquitination chain of YAP.•USP40 facilitates HCC cell proliferation and migration by enhancing YAP expression.•YAP transcriptionally activated USP40 expression in HCC cells.•USP40 and YAP overexpression were frequently detected and correlated with poor prognosis in HCC.</description><subject>Hepatocellular carcinoma</subject><subject>Stiffness</subject><subject>Tumor progression</subject><subject>USP40</subject><subject>YAP</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxEAQRRtRdHz8gUiWbjL2M51sBBFfICioCzc2_ag4PSbpsTsR_HszZHTpqjbnVtU9CB0TPCeYFGfLudVdA_2cYsrnlBQlo1toRkpJc1mVeBvNMMM8ZyUTe2g_pSXGWHApdtEeKwWTUvIZent5euQ4W8XQhh5StoCV7oOFphkaHTOro_VdaPWaeI-Qkg9d1i9iGN4Xmc5eLx7PNhtC8r3_gqwGcEbbj6wJYXWIdmrdJDjazAP0cn31fHmb3z_c3F1e3OeWEdLnTgMVRjhXaYGJcVowURBZ1YJwI6jhBTOGCl05qConSlkXpCa1tJIZXeCKHaDTae_45ucAqVetT-sWuoMwJMUw4ZhQxsmI8gm1MaQUoVar6FsdvxXBam1WLdVkVq3NqsnsGDvZXBhMC-4v9KtyBM4nAMaeXx6iStZDZ8H5CLZXLvj_L_wAWAqLoA</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Mo, Huanye</creator><creator>Li, Runtian</creator><creator>Yang, Nan</creator><creator>Han, Jiaqi</creator><creator>Xiao, Xuelian</creator><creator>Zhang, Yilei</creator><creator>Xiao, Zhengtao</creator><creator>Jiao, Lianying</creator><creator>Xu, Qiuran</creator><creator>Tu, Kangsheng</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0032-1459</orcidid></search><sort><creationdate>20240501</creationdate><title>USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop</title><author>Mo, Huanye ; Li, Runtian ; Yang, Nan ; Han, Jiaqi ; Xiao, Xuelian ; Zhang, Yilei ; Xiao, Zhengtao ; Jiao, Lianying ; Xu, Qiuran ; Tu, Kangsheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-dae25b5dd9a501bda5356179f514b52b463bb25a9de99d587f61f1f7c73ba6093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Hepatocellular carcinoma</topic><topic>Stiffness</topic><topic>Tumor progression</topic><topic>USP40</topic><topic>YAP</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mo, Huanye</creatorcontrib><creatorcontrib>Li, Runtian</creatorcontrib><creatorcontrib>Yang, Nan</creatorcontrib><creatorcontrib>Han, Jiaqi</creatorcontrib><creatorcontrib>Xiao, Xuelian</creatorcontrib><creatorcontrib>Zhang, Yilei</creatorcontrib><creatorcontrib>Xiao, Zhengtao</creatorcontrib><creatorcontrib>Jiao, Lianying</creatorcontrib><creatorcontrib>Xu, Qiuran</creatorcontrib><creatorcontrib>Tu, Kangsheng</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mo, Huanye</au><au>Li, Runtian</au><au>Yang, Nan</au><au>Han, Jiaqi</au><au>Xiao, Xuelian</au><au>Zhang, Yilei</au><au>Xiao, Zhengtao</au><au>Jiao, Lianying</au><au>Xu, Qiuran</au><au>Tu, Kangsheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>589</volume><spage>216832</spage><epage>216832</epage><pages>216832-216832</pages><artnum>216832</artnum><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Yes-associated protein (YAP) is an essential driver of hepatocellular carcinoma (HCC) progression and the ubiquitin-proteasome system controls its abundance. However, the role of ubiquitin-specific protease 40 (USP40) in YAP stability remains unclear. Here, USP40 was first identified as a novel regulator of YAP abundance and its target genes in HCC cells. USP40 interacted with YAP to remove the lysine 48 (K48)-linked polyubiquitination of YAP at K252 and K315 sites, thereby maintaining YAP stability. USP40 facilitated the proliferation, colony formation, migration and spheroid formation of HCC cells in vitro and promoted HCC growth in vivo in a YAP-dependent manner. In turn, YAP transcriptionally activated USP40 expression in HCC cells. RNA sequencing analysis showed that about 37% of USP40-regulated genes overlapped with YAP-regulated genes. Interestingly, stiffness-induced USP40 upregulation was abolished by YAP knockdown, and USP40 knockdown attenuated stiffness-induced YAP accumulation in HCC cells. Clinical data demonstrated that USP40 was positively associated with YAP expression in HCC tissues and its high expression indicated a poor prognosis. In conclusion, the USP40/YAP positive feedback loop contributes to HCC progression, suggesting that USP40 may be a promising drug target for anti-HCC. •USP40 stabilizes YAP by removing the polyubiquitination chain of YAP.•USP40 facilitates HCC cell proliferation and migration by enhancing YAP expression.•YAP transcriptionally activated USP40 expression in HCC cells.•USP40 and YAP overexpression were frequently detected and correlated with poor prognosis in HCC.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38537774</pmid><doi>10.1016/j.canlet.2024.216832</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0032-1459</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2024-05, Vol.589, p.216832-216832, Article 216832
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_3014012341
source Elsevier ScienceDirect Journals Collection
subjects Hepatocellular carcinoma
Stiffness
Tumor progression
USP40
YAP
title USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A38%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=USP40%20promotes%20hepatocellular%20carcinoma%20progression%20through%20a%20YAP/USP40%20positive%20feedback%20loop&rft.jtitle=Cancer%20letters&rft.au=Mo,%20Huanye&rft.date=2024-05-01&rft.volume=589&rft.spage=216832&rft.epage=216832&rft.pages=216832-216832&rft.artnum=216832&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2024.216832&rft_dat=%3Cproquest_cross%3E3014012341%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3014012341&rft_id=info:pmid/38537774&rft_els_id=S0304383524002258&rfr_iscdi=true